Histiocytoma, Malignant Fibrous
"Histiocytoma, Malignant Fibrous" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The most commonly diagnosed soft tissue sarcoma. It is a neoplasm with a fibrohistiocytic appearance found chiefly in later adult life, with peak incidence in the 7th decade.
MeSH Number(s)
C04.557.450.565.590.425.360
C04.557.450.795.400
Concept/Terms
Histiocytoma, Malignant Fibrous- Histiocytoma, Malignant Fibrous
- Fibrous Histiocytoma, Malignant
- Fibrous Histiocytomas, Malignant
- Histiocytomas, Malignant Fibrous
- Malignant Fibrous Histiocytomas
- Malignant Fibrohistiocytic Tumors
- Fibrohistiocytic Tumor, Malignant
- Fibrohistiocytic Tumors, Malignant
- Malignant Fibrohistiocytic Tumor
- Tumor, Malignant Fibrohistiocytic
- Tumors, Malignant Fibrohistiocytic
- Malignant Fibrous Histiocytoma
Below are MeSH descriptors whose meaning is more general than "Histiocytoma, Malignant Fibrous".
Below are MeSH descriptors whose meaning is more specific than "Histiocytoma, Malignant Fibrous".
This graph shows the total number of publications written about "Histiocytoma, Malignant Fibrous" by people in Harvard Catalyst Profiles by year, and whether "Histiocytoma, Malignant Fibrous" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2005 | 1 | 0 | 1 |
2006 | 1 | 0 | 1 |
2007 | 2 | 0 | 2 |
2008 | 3 | 0 | 3 |
2009 | 2 | 0 | 2 |
2010 | 2 | 2 | 4 |
2011 | 2 | 1 | 3 |
2012 | 1 | 1 | 2 |
2013 | 1 | 0 | 1 |
2014 | 2 | 1 | 3 |
2017 | 0 | 1 | 1 |
2019 | 1 | 1 | 2 |
2020 | 1 | 0 | 1 |
2021 | 4 | 0 | 4 |
2022 | 1 | 0 | 1 |
2023 | 2 | 0 | 2 |
2024 | 2 | 0 | 2 |
Below are the most recent publications written about "Histiocytoma, Malignant Fibrous" by people in Profiles.
-
ASO Author Reflections: Does Wound VAC Temporization Offer Similar Patient-Reported Outcomes as Single-Stage Excision Reconstruction After Myxofibrosarcoma Resection? Ann Surg Oncol. 2024 Apr; 31(4):2786-2788.
-
Does Wound VAC Temporization Offer Patient-Reported Outcomes Similar to Single-Stage Excision Reconstruction After Myxofibrosarcoma Resection? Ann Surg Oncol. 2024 Apr; 31(4):2757-2765.
-
Gene fusions in superficial mesenchymal neoplasms: Emerging entities and useful diagnostic adjuncts. Semin Diagn Pathol. 2023 Jul; 40(4):246-257.
-
Prognostic and predictive factors in undifferentiated pleomorphic sarcoma: A long-term study from a large tertiary care urban center. J Surg Oncol. 2023 Aug; 128(2):322-331.
-
Separation Surgery and Postoperative Intensity-Modulated Radiation Therapy for a High-Grade Myxofibrosarcoma Involving the Spine: A Case Report. Am J Case Rep. 2023 Mar 09; 24:e939368.
-
Durable response to crizotinib in metastatic angiomatoid fibrous histiocytoma with EWSR1-CREB1 fusion and ALK overexpression. Ann Oncol. 2022 08; 33(8):848-850.
-
Intracranial mesenchymal tumors with FET-CREB fusion are composed of at least two epigenetic subgroups distinct from meningioma and extracranial sarcomas. Brain Pathol. 2022 07; 32(4):e13037.
-
Generation of human embryonic stem cell models to exploit the EWSR1-CREB fusion promiscuity as a common pathway of transformation in human tumors. Oncogene. 2021 08; 40(32):5095-5104.
-
ASO Author Reflections: VAC Dressing in Staging Myxofibrosarcoma Resection in the Extremities: Is it Safe? Ann Surg Oncol. 2021 12; 28(13):9177-9178.
-
Intracranial mesenchymal tumor with FET-CREB fusion-A unifying diagnosis for the spectrum of intracranial myxoid mesenchymal tumors and angiomatoid fibrous histiocytoma-like neoplasms. Brain Pathol. 2021 07; 31(4):e12918.